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http:WHAT THIS PAPER ADDS
The morphology, angulation and degree of carotid stenosis in patients undergoing CAS did not predict the
occurrence of new DWI-positive brain lesions. Patients should not be excluded from CAS based on their carotid
anatomy.Introduction: The International Carotid Stenting Study (ICSS, ISRCTN25337470) randomized patients with
recently symptomatic carotid artery stenosis > 50% to carotid artery stenting (CAS) or endarterectomy. CAS
increased the risk of new brain lesions visible on diffusion-weighted magnetic resonance imaging (DWI-MRI)
more than endarterectomy in the ICSS-MRI Substudy. The predictors of new post-stenting DWI lesions were
assessed in these patients.
Methods: ICSS-MRI Substudy patients allocated to CAS were studied. Baseline or pre-stenting catheter
angiograms were rated to determine carotid anatomy. Baseline patient demographics and the inﬂuence of
plaque length, plaque morphology, internal carotid angulation, and external or common carotid atheroma were
examined in negative binomial regression models.
Results: A total of 115 patients (70% male, average age 70.4) were included; 50.4% had at least one new DWI-
MRI-positive lesion following CAS. Independent risk factors increasing the number of new lesions were a left-
sided stenosis (incidence risk ratio [IRR] 1.59, 95% CI 1.04e2.44, p ¼ .03), age (IRR 2.10 per 10-year increase in
age, 95% CI 1.61e2.74, p < .01), male sex (IRR 2.83, 95% CI 1.72e4.67, p < .01), hypertension (IRR 2.04, 95% CI
1.25e3.33, p < .01) and absence of cardiac failure (IRR 6.58, 95% CI 1.23e35.07, p ¼ .03). None of the carotid
anatomical features signiﬁcantly inﬂuenced the number of post-procedure lesions.
Conclusion: Carotid anatomy seen on pre-stenting catheter angiography did not predict of the number of
ischaemic brain lesions following CAS.
 2015 The Authors. Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. This is an open
access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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//dx.doi.org/10.1016/j.ejvs.2015.08.012Carotid artery stenting (CAS) is an endovascular alternative
to carotid endarterectomy (CEA) for the long-term preven-
tion of recurrent stroke in patients with carotid atheroma.
CAS was tested against CEA in the International Carotid
Stenting Study (ICSS), a large randomized controlled trial
recruiting symptomatic patients with greater than 50% ca-
rotid artery stenosis. Interim analysis of this trial demon-
strated an excess of stroke, death, or myocardial infarction
in patients randomized to CAS, mostly attributable to an
excess of minor stroke.1 This observation was reinforced in
the ICSS-MRI Substudy, which found a 50% incidence of
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trial compared with just 17% of patients receiving CEA (OR
5.21, 95% CI 2.78e9.79, p< .01).2 Patients in the CAS group
had a greater number of lesions, and these lesions were
more likely to occur in cortical and in adjacent white matter
areas.3
CAS requires the passage of devices through the vascu-
lature up to or beyond the stenotic lesion. Vascular
anatomical variants and atheromatous lesion characteristics
have therefore been proposed as contributing to a techni-
cally challenging procedure4 or a higher burden of ischae-
mic brain lesions post procedure.5 The study aimed to
investigate the effects of carotid vascular anatomy and
plaque morphology on the occurrence of new ischaemic
brain lesions on diffusion-weighted magnetic resonance
imaging (DWI-MRI) following CAS, and whether there are
patient or procedural factors that place patients at higher
risk of this complication.
METHODS
ICSS-MRI substudy
The ICSS-MRI Substudy was contained within the Interna-
tional Carotid Stenting Study, which randomized patients to
either CAS or CEA. Full inclusion and exclusion criteria are
published in the ICSS protocol.6 The clinical short-term and
long-term outcomes have been previously published.1,7
Centres participating in the ICSS-MRI substudy are pub-
lished elsewhere.2 In summary, patients older than 40 years
were required to have > 50% recently symptomatic carotid
artery stenosis, be suitable for either surgery or stenting,
and be capable of giving informed consent. Patients were
excluded from randomization in ICSS if CAS was judged
unsuitable because of pseudo-occlusion of the artery (ste-
nosis  95% with collapsed distal lumen), tortuous vascular
anatomy proximal or distal to the stenosis, proximal com-
mon carotid artery stenosis, or plaque thrombus visible on
imaging. CAS was carried out by accredited interventionists
according to a strict protocol.6 A cerebral protection device
(CPD) was recommended where one could be “safely
deployed”. Dual antiplatelet therapy to cover the procedure
and for a minimum of 4 weeks thereafter was speciﬁed in
the protocol.
Patients in the MRI substudy underwent pre-procedural
MRI up to 7 days before CAS. Post-procedure MRI was
performed 1e3 days after CAS. All imaging protocols
included diffusion-weighted imaging sequences to demon-
strate areas of acute or subacute brain ischaemia or
infarction. DWI lesion count was determined by the
consensus reading of a neurologist and neuroradiologist
blind to treatment allocation.2,3 Age-related white matter
changes (ARWMC) on brain imaging were rated by two
investigators as proposed by Wahlund and colleagues.8,9
Patients in this analysis were those in the ICSS-MRI
substudy in whom the allocated procedure of CAS was
initiated and a baseline or pre-stenting intra-arterial cath-
eter angiogram was available. Baseline patient characteris-
tics were recorded by investigators at each centre at thetime of the patient’s enrolment in the study. These included
the side of the stenosis, vascular risk factors such as base-
line blood pressure and cholesterol, and whether hyper-
tension or hypercholesterolaemia were treated, a diagnosis
of diabetes, heart failure, peripheral vascular disease or
cardiac failure, and baseline disability as measured by the
modiﬁed Rankin scale (mRS).
ICSS was approved by the Northwest Multicentre
Research Ethics Committee in the UK. Individual partici-
pating centres obtained site-speciﬁc approval from their
local ethics committees.Anatomical rating methods
Baseline catheter angiography, performed at the time of
enrolment into the trial or procedural angiography prior to
stent deployment was evaluated by a trained reader
(B.M.H.). A second trained reader (D.D.) made comparator
measurements to enable inter-rater reliability to be deﬁned.
Both readers were blind to our selected outcome of lesion
count at the time of reading. Standard deﬁnitions were
developed for rating anatomies. The degree of stenosis in
the ipsilateral treated artery was calculated using the
NASCET formula10: the narrowest residual lumen compared
with the distal ICA diameter. Ulceration or plaque irregu-
larity was deﬁned in accordance with NASCET plaque
morphology rating, being ulcerated when “seen in proﬁle as
a crater penetrating into a stenotic plaque”.11 The angle
between the common carotid artery (CCA) and internal
carotid artery (ICA) was calculated. “Pinhole” stenosis was
deﬁned as an arterial lumen too small to accurately mea-
sure but with normal distal runoff. “Length of stenosis” was
deﬁned as the distance between proximal and distal
shoulders of the lesion where the luminal diameter
decreased to 20% of its maximum, expressed as a fraction
of the CCA diameter on angiography views that most
elongated that stenosis.12 The CCA was judged to be
“diseased” with atheroma if there was deﬁnite plaque
encroaching on the lumen or irregularity in the lumen
consistent with atherosclerosis. Views of the contralateral
carotid artery were not routinely available; therefore the
measurement of contralateral stenosis provided by the local
investigator at the point of entry into the trial was used.
DICOM images were read using the open-source software
Osirix MD, Pixmeo SARL (2012).Statistical methods
Negative binomial regression models were constructed for
each risk factor investigated. Comparisons between a
reference group and the factor under consideration are
expressed as incidence risk ratios (IRRs) with a 95% Wald
conﬁdence interval, quantifying how many times more or
fewer lesions occurred. Factors with p < .05, considered
signiﬁcant in all analyses, were considered for entry into a
multivariable model. Inter-rater agreement for vascular
anatomical variables was assessed by means of a kappa (k)
statistic as proposed by Landis and Koch.13 Statistical
16 D. Doig et al.analyses were performed using SPSS version 22.0.0.0, IBM
Corp (Armonk, NY, USA).Table 1. Baseline and measured characteristics of patients
included in the analysis.
Parameter Number of patients
(%) total n ¼ 115
Demographic and technical
Right-sided stenosis 61 (53%)
Cerebral protection device used 46 (40%)
Age, years (mean, standard deviation) 70.4 (SD ¼ 9.50)
Female 34 (30%)
Hypertension 77 (67%)
Diabetes (any type) 22 (19%)
Treated hyperlipidaemia 71 (62%)
Current or former smoker 87 (76%)
Coronary heart disease 26 (23%)
Other cardioembolic source of thrombus 7 (6%)
Cardiac failure 3 (3%)
Peripheral arterial disease 21 (18%)
Contralateral carotid occlusion 7 (6%)
Contralateral carotid stenosis 70e99% 23 (20%)
Contralateral carotid stenosis 50e69% 12 (10%)
Contralateral carotid stenosis < 50% 73 (64%)RESULTS
Baseline patient and procedural characteristics
A total of 231 patients were randomized in the ICSS-MRI
substudy, of whom 127 were randomized to CAS. Baseline
(n ¼ 7) or pre-procedure (n ¼ 110) catheter angiography,
with views adequate to assess anatomical characteristics,
was available for 115 patients, all of whom were included in
this analysis (2 patients had both baseline and pre-
procedure imaging). The mean age was 70.4 years; 70% of
patients were male. Vascular risk factors were common, as
detailed in Table 1. Forty-seven per cent of procedures were
carried out on the left carotid, 53% on the right. A pro-
tection device was used in 46 out of 115 (40.0%) pro-
cedures, of which 91% were distal ﬁlter type and 9% were
ﬂow reversal systems. Overall, the median carotid stenosis
was 62.7% (IQR 52.0e78.9). Plaque morphology showed
ulceration in 40 patients (35%). Angulation and external
carotid artery (ECA) disease were less common. A quarter
(30, 26%) had severe contralateral carotid artery disease.
Following CAS 62/115 (50.4%) of patients had at least one
new DWI-MRI-positive lesion on their post-procedure scan.
Details of the distribution of lesion count can be found in
Gensicke et al.3(reference group)
Baseline modiﬁed Rankin Scale score
(mRS) ¼ 4
2 (2%)
Baseline mRS ¼ 3 6 (5%)
Baseline mRS ¼ 2 28 (24%)
Baseline mRS ¼ 1 29 (25%)
Baseline mRS ¼ 0 (reference group) 50 (44%)
Cholesterol (mean, standard deviation) 4.9 mmol/L
(SD ¼ 1.34)
Baseline diastolic blood pressure (mean,
standard deviation)
83.0 mmHg
(SD ¼ 12.7)
Baseline systolic blood pressure (mean,
standard deviation)
157.3 mmHg
(SD ¼ 26.1)
Median age-related white matter change
score (ARWMC)
4
Qualifying event was stroke 49 (43%)
Qualifying event was transient ischaemic
attack (TIA)
41 (36%)
Qualifying event was retinal TIA or
retinal stroke
25 (22%)
Vascular anatomical characteristics
Carotid artery NASCET degree of
stenosis (median, interquartile range)
62.7
(IQR 52.0e78.9)
Ratio of maximal stenosis length to
common carotid artery diameter
(median, interquartile range)
0.41
(IQR 0.26e0.65)
Angle between common and internal
carotid arteries (median, interquartile
range)
23.6
(IQR 15.6e35.9)
External carotid artery stenosis >50% 6 (5%)
Plaque ulceration 40 (35%)
Pinhole stenosis 2 (2%)
Common carotid artery atheroma 13 (11%)Univariable results
Table 2 summarizes the results of analysis of patient de-
mographic, vascular anatomical characteristics and proce-
dural factors in a negative binomial regression analysis. The
number of new DWI-MRI lesions at 1e3 days after the CAS
procedure was associated with increasing age (IRR 2.26 for
each 10-year increase in age, 95% CI 1.74e2.89, p < .01),
hypertension (IRR 2.61, 95% CI 1.68e4.05, p < .01), with
increasing ARWMC (IRR 1.13 for each point increase, 95% CI
1.06e1.20, p < .01), and with stroke or transient ischaemic
attack (TIA) as the qualifying event for entry into ICSS,
compared with those with a retinal event (IRR 4.30, 95% CI
2.46e7.53, p < .01 for stroke, IRR 1.91, 95% CI 1.06e3.43,
p ¼ .03 for TIA). The number of new DWI lesions was
signiﬁcantly lower in female patients (IRR 0.49, 95% CI
0.31e0.76, p < .01) and current or former smokers than in
those who had never smoked (IRR 0.48, 95% CI 0.31e0.76,
p < .01), those with cardiac failure (IRR 0.17, 95% CI 0.03e
0.85, p ¼ .03), those with 50e69% contralateral carotid
stenosis than in those with < 50% contralateral carotid
stenosis (IRR 0.18, 95% CI 0.08e0.40, p < .01) and in those
with a modiﬁed Rankin scale score (mRS) of 3 at baseline
compared to those with an mRS score of 0 (IRR 0.20, 95% CI
0.06e0.62, p < .01). None of the anatomical variables
(degree and length of ipsilateral stenosis, the CCA to ICA
angle, ECA stenosis, carotid ulceration, or the presence of
CCA atheroma) measured on ipsilateral pre-procedure
angiography predicted the occurrence of new DWI-MRI le-
sions post procedure. However, right-sided stenosis wasassociated with a lower rate of new lesions versus left-sided
stenosis.Multivariable model
Factors with signiﬁcance p < .05 were considered for entry
into a multivariable model. After adjustment for other
Table 2. Univariable predictors of new DWI-MRI lesions following CAS in 115 patients.
Parameter p Incidence Risk Ratio (IRR) 95% Conﬁdence
interval for IRR
Lower Upper
Demographic and technical
Right-sided stenosis < .01 0.57 0.38 0.85
Cerebral protection device used .22 1.30 0.86 1.95
Age (per 10-year increase) < .01 2.26 1.74 2.89
Female < .01 0.49 0.31 0.76
Hypertension < .01 2.61 1.68 4.05
Diabetes (any type) .07 1.59 0.97 2.61
Treated hyperlipidaemia .69 0.92 0.61 1.38
Current or former smoker < .01 0.48 0.31 0.76
Coronary heart disease .43 1.21 0.76 1.94
Other cardioembolic source of thrombus .28 1.56 0.69 3.49
Cardiac failure .03 0.17 0.03 0.85
Peripheral arterial disease .29 0.75 0.45 1.27
Contralateral carotid occlusion .21 1.69 0.75 3.80
Contralateral carotid stenosis 70e99% .12 0.66 0.39 1.11
Contralateral carotid stenosis 50e69% < .01 0.18 0.08 0.40
Contralateral carotid stenosis < 50% (reference
group)
N/A 1 N/A N/A
Baseline modiﬁed Rankin Scale score (mRS) ¼ 4 .14 0.26 0.04 1.57
Baseline mRS ¼ 3 < .01 0.20 0.06 0.62
Baseline mRS ¼ 2 .20 1.38 0.84 2.26
Baseline mRS ¼ 1 .40 0.81 0.49 1.33
Baseline mRS ¼ 0 (reference group) N/A 1 N/A N/A
Cholesterol (per 1 mmol increase in serum total
cholesterol)
.30 0.89 0.71 1.11
Baseline diastolic blood pressure (per 10 mmHg
increase)
.13 0.90 0.79 1.03
Baseline systolic blood pressure (per 10 mmHg
increase)
.98 1.00 0.91 1.09
Age-related white matter changes score (per unit
increase)
< .01 1.13 1.06 1.20
Qualifying event was stroke < .01 4.30 2.46 7.53
Qualifying event was transient ischaemic attack
(TIA)
.03 1.91 1.06 3.43
Qualifying event was retinal TIA or retinal stroke
(reference group)
N/A 1 N/A N/A
Vascular anatomical characteristics
Carotid artery NASCET degree of stenosis (per
10% increase)
.69 0.97 0.83 1.13
Ratio of maximal stenosis length to common
carotid artery diameter (per unit increase)
.46 1.28 0.67 2.45
Angle between common and internal carotid
arteries
.12 0.99 0.98 1.00
External carotid artery stenosis > 50% .08 0.42 0.16 1.10
Plaque ulceration .66 1.10 0.73 1.66
Pinhole stenosis .88 1.13 0.25 5.05
Common carotid artery atheroma .69 0.88 0.47 1.65
Predictors of New Ischaemic Brain Lesions 17characteristics, the type of qualifying event, smoking status,
and baseline disability were no longer signiﬁcant predictors.
Table 3 illustrates one possible multivariable model with
ﬁve simple clinical characteristics e the side of the proce-
dure, age, sex, hypertension, and cardiac failure. Indepen-
dent risk factors increasing the number of new DWI-MRI
lesions following CAS were age (IRR 2.10 per 10-year in-
crease in age, 95% CI 1.61e2.74, p < .01), hypertension
(IRR 2.04, 95% CI 1.25e3.33, p < .01), a left-sided stenosis(IRR 1.59, 95% CI 1.04e2.44, p ¼ .03), male sex (IRR 2.83,
95% CI 1.72e4.67, p < .01), and an absence of cardiac
failure (IRR 6.58, 95% CI 1.23e35.07, p ¼ .03).Inter-rater reliability
Inter-rater agreement was moderate for CCA atheroma
(k ¼ 0.50, p < .01), substantial for the type of stenosis
(smooth, irregular or ulcerated, k ¼ 0.76, p < .01), and
slight for pinhole stenosis (k ¼ 0.13, p ¼ .06).
Table 3. Independent predictors of new DWI-MRI lesions following
CAS in 115 patients.
Parameter p Incidence Risk
Ratio (IRR)
95%
Conﬁdence
interval for
IRR
Lower Upper
Left-sided stenosis .03 1.59 1.04 2.44
Age (per 10-year
increase)
< .01 2.10 1.61 2.74
Male < .01 2.83 1.72 4.67
Hypertension < .01 2.04 1.25 3.33
No diagnosis of cardiac
failure
.03 6.58 1.23 35.07
18 D. Doig et al.DISCUSSION
In this study of patients in the ICSS-MRI Substudy, anatomy
of the carotid artery or plaque morphology was not found
to predict the number of new post-procedure DWI-MRI
lesions following intervention by CAS. Consequently, the
increased event rate following CAS could not be explained
by inclusion of patients with higher risk carotid anatomy.
Expert opinion has proposed that certain vascular anato-
mies render CAS more difﬁcult, such as vessel angulation or
tortuosity or aortic arch variants.4 Other authors have
determined a number of variables that could speciﬁcally
affect the risk of new DWI brain lesions following CAS,
including age,5 an ulcerated stenosis,5 aortic atherosclerotic
lesions,14 and increasing lesion length.5 Studies measuring
clinical outcomes of stroke or peri-procedural stroke, death,
or myocardial infarction have suggested lesion characteris-
tics such as length,12,15,16 plaque ulceration or calciﬁca-
tion,15 aortic arch anatomy,15,17 ICAeCCA angulation,16 and
the side of the procedure16 inﬂuence the risk of complica-
tions. In this analysis, a higher number of lesions were
noted in left-sided procedures, perhaps reﬂecting increased
difﬁculty in access to the CCA on this side.16 However, the
ﬁndings of others regarding the inﬂuence of pinhole ste-
nosis, length of stenosis, or ICAeCCA angulation on pro-
cedural risk could not be replicated.
At most centres in ICSS the anatomical suitability of the
stenosis for CAS and CEA was determined prior to
randomization using non-invasive imaging such as ultra-
sound, computed tomography (CT) angiography or mag-
netic resonance (MR) angiography. Pre-stenting catheter
angiograms were primarily obtained to plan the procedures;
the ﬁlms available for analysis usually did not include the
aortic arch and did not allow assessment of all angles in the
CCA and ICA. Another possible explanation for the lack of an
association between DWI lesions and anatomical parame-
ters is that patients thought to be at high risk from stenting
were excluded from taking part in ICSS. Indeed, the trial
protocol speciﬁcally excluded patients with a stenosis that
was known to be unsuitable for stenting prior to randomi-
zation.6 Thus a relatively low percentage of patients with
pinhole stenosis or angulation of the CCAeICA junction are
reported. We also note low inter-rater reliability in other
studies for some characteristics measured11 in agreementwith the results of this study. This represents a major limi-
tation if vascular characteristics are proposed for patient
selection: there should be reliable agreement as to which
patients may be at increased risk. In the future, access to
advanced plaque imaging, perhaps with MRI, could increase
the accuracy and reliability of pre-procedure plaque char-
acterization by examining plaque characteristics and
morphology.
Older patients experienced a higher number of new
ischaemic brain lesions following CAS in the ICSS-MRI Sub-
study, and an association between the total volume of DWI
lesions and hemispheric stroke in this patient group has
previously been demonstrated.2 This ﬁnding echoes clinical
data from the Carotid Stenting Trialists’ Collaboration,
which conducted an individual patient data meta-analysis of
the large European trials of CAS versus CEA, namely ICSS,1
EVA-3S,18 and SPACE.19 This found a twofold increase in
the risk of stroke, death, or myocardial infarction within 30
days of CAS compared with CEA in patients over the age of
70 years.20 The mechanism by which age increases risk is
not apparent from this study, but may be related to an
underlying increase in the burden of atheroma over time or
a decreased ability to tolerate reduced blood ﬂow in the
brain after embolism. Changes in aortic arch anatomy and
atherosclerotic burden with age may also explain concerns
about the formation of new DWI lesions following cardiac
catheterization where the carotid artery is not cathe-
terized.21 Male patients and those with hypertension also
experienced an increased number of post-procedure DWI
lesions. Although it is difﬁcult to postulate a direct causal
mechanism for this, unmeasured factors in these patients,
such as the type of plaque (haemorrhagic, lipid-rich) or the
total plaque burden, may have made a greater contribution
to inadvertent embolization during the procedure. Large-
scale registries, such as that of Medicare patients in the
United States undergoing CAS, suggest a similar risk of mi-
nor stroke within 30 days of CAS in men and women,22 and
therefore the excess of ischaemic lesions in men in our
study may be subclinical. Other unmeasured variables may
confound the ﬁndings with respect to cardiac failure; for
example, it is possible that patients with this diagnosis
received more appropriate antiplatelet cover for the pro-
cedure than others.
The ﬁnding that CPD use did not protect against new DWI
lesions agrees with two small randomized studies of pro-
tected versus unprotected CAS which used MRI up to 24
hours after the procedure to look for evidence of peri-
procedural cerebral ischaemia.23,24 Some studies report
that CPDs do reduce emboli, but even these analyses show
that DWI lesions still frequently occur following protected
CAS.25,26 Most CPDs used in ICSS were distal ﬁlters, and
research continues to determine whether newer ﬂow-
reversal types of CPD may confer better protection.27Limitations
This analysis has a number of important limitations. Views
on catheter angiography were limited, and it was not
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of the ICA, the proximal CCA, or the aortic arch, all of which
may be important areas of technical difﬁculty in the CAS
procedure. It should be noted that CPD use in ICSS was
recommended when safe, but still at the interventionist’s
discretion. Thus the comparison between patients with CPD
or no CPD is not a randomized comparison. Anatomical
analysis was performed on catheter angiography, but in
current practice selection of patients for CAS is likely to be
based on CT angiography or MR angiography. However, it is
expected that many of the features that were identiﬁed,
including pinhole stenosis, ICA angulation, and plaque
length, would correlate well with the equivalent measure-
ments on non-invasive imaging. No corrections were made
for multiple statistical comparisons in univariable analysis,
given the low number of patients with an outcome event
(n ¼ 62) and the limited power to detect a true difference,
giving rise to the possibility of type I (false positive) errors in
interpretation.CONCLUSION
In patients otherwise matching the inclusion and exclusion
criteria for ICSS, there is no reason to exclude patients from
stenting on the basis of individual vascular anatomical
characteristics measured in the analysis. However, patient
characteristics such as age and sex should be taken into
account when selecting for CAS.CONFLICT OF INTEREST
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